376 related articles for article (PubMed ID: 8671368)
1. Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation.
Weissman A; Loumaye E; Shoham Z
Hum Reprod; 1996 May; 11(5):943-9. PubMed ID: 8671368
[TBL] [Abstract][Full Text] [Related]
2. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
Shoham Z; Howles CM; Zalel Y; Weissman A; Insler V
Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
[TBL] [Abstract][Full Text] [Related]
3. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
Gerris J; De Vits A; Joostens M; Van Royen E
Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of exogenous human chorionic gonadotrophin on progesterone production from normal or malfunctioning corpus luteum.
Momoeda M; Tsutsumi O; Morita Y; Igarashi T; Suenaga A; Osuga Y; Shiotsu H; Yano T; Taketani Y
Hum Reprod; 1998 Jul; 13(7):1907-11. PubMed ID: 9740447
[TBL] [Abstract][Full Text] [Related]
5. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
Valbuena D; Pellicer A; Guanes PP; Remohí J; Simón C
Hum Reprod; 1997 Oct; 12(10):2118-22. PubMed ID: 9402265
[TBL] [Abstract][Full Text] [Related]
6. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
7. Effect of gonadotrophin-releasing hormone agonist-induced suppression of LH and FSH on follicle growth and corpus luteum function in the ewe.
McNeilly AS; Fraser HM
J Endocrinol; 1987 Nov; 115(2):273-82. PubMed ID: 3125300
[TBL] [Abstract][Full Text] [Related]
8. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
Kuhl H; Jung C; Taubert HD
Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
[TBL] [Abstract][Full Text] [Related]
9. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization.
Beckers NG; Laven JS; Eijkemans MJ; Fauser BC
Hum Reprod; 2000 Jan; 15(1):43-9. PubMed ID: 10611186
[TBL] [Abstract][Full Text] [Related]
10. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
[TBL] [Abstract][Full Text] [Related]
11. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
Yuen BH; Sy L; Cannon W
Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
[TBL] [Abstract][Full Text] [Related]
12. Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol.
Smitz J; Erard P; Camus M; Devroey P; Tournaye H; Wisanto A; Van Steirteghem AC
Hum Reprod; 1992 Oct; 7(9):1225-9. PubMed ID: 1479002
[TBL] [Abstract][Full Text] [Related]
13. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
14. Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist.
Donderwinkel PF; Schoot DC; Pache TD; de Jong FH; Hop WC; Fauser BC
Hum Reprod; 1993 Dec; 8(12):2027-32. PubMed ID: 8150898
[TBL] [Abstract][Full Text] [Related]
15. Endocrine responses to gonadotrophins after LHRH agonist administration on cycle days 1-4: prevention of premature luteinization.
Martikainen H; Rönnberg L; Tapanainen J; Puistola U; Orava M; Kauppila A
Hum Reprod; 1990 Apr; 5(3):246-9. PubMed ID: 2112552
[TBL] [Abstract][Full Text] [Related]
16. Local changes in blood flow within the preovulatory follicle wall and early corpus luteum in cows.
Acosta TJ; Hayashi KG; Ohtani M; Miyamoto A
Reproduction; 2003 May; 125(5):759-67. PubMed ID: 12713439
[TBL] [Abstract][Full Text] [Related]
17. A bolus of recombinant human follicle stimulating hormone at midcycle induces periovulatory events following multiple follicular development in macaques.
Zelinski-Wooten MB; Hutchison JS; Hess DL; Wolf DP; Stouffer RL
Hum Reprod; 1998 Mar; 13(3):554-60. PubMed ID: 9572409
[TBL] [Abstract][Full Text] [Related]
18. Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle.
Hofmann GE; Bergh PA; Guzman I; Masuku S; Navot D
Hum Reprod; 1993 May; 8(5):695-8. PubMed ID: 8314961
[TBL] [Abstract][Full Text] [Related]
19. Serum gonadotropin and steroid patterns in early human gestation.
Mishell DR; Thorneycroft IH; Nagata Y; Murata T; Nakamura RM
Am J Obstet Gynecol; 1973 Nov; 117(5):631-42. PubMed ID: 4742372
[TBL] [Abstract][Full Text] [Related]
20. Effect of follicle stimulating hormone or human chorionic gonadotrophin treatment on the production of gonadotrophin surge attenuating factor (GnSAF) during the luteal phase of the human menstrual cycle.
Messinis IE; Lolis D; Zikopoulos K; Milingos S; Kollios G; Seferiadis K; Templeton AA
Clin Endocrinol (Oxf); 1996 Feb; 44(2):169-75. PubMed ID: 8849571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]